Brochures

This toolkit serves as a guide on coding and the appeals process.

Tianna* is 35, has normal cytology and HPV 31. If she was your patient, what would you do? Learn how individually identifying HPV 31 can benefit your patients like Tianna.

Learn more about how the BD Vaginal Panel provides a more accurate vaginitis diagnosis as compared to traditional methods.

Learn more about how the BD Vaginal Panel and the BD CTGCTV2 assay can help decrease the number of recurrent visits, incorrect treatments and negative sequelae associated with vaginits and STIs.

Learn more about the importance of HPV 31 and the BD Onclarity™ HPV Assay with extended genotyping, the only FDA-approved HPV test that individually identifies HPV 31.

Learn more about the benefits of extended genotyping and the BD Onclarity™ HPV Assay, the only FDA-approved HPV test with extended genotyping, that identifies genotypes beyond 16 and 18, including 31.